✦ LIBER ✦

PCN138 Geographic Variation and Socio-Demographic Disparity in the Utilization of Oxaliplatin-Containing Chemotherapy in Patients with Stage-III Colon Cancer

✍ Scribed by Panchal, J.; Lairson, D.; Chan, W.; Du, X.L.

Book ID: 122126410
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.03.1255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Geographic Variation and Sociodemographi

Geographic Variation and Sociodemographic Disparity in the Use of Oxaliplatin-Containing Chemotherapy in Patients With Stage III Colon Cancer

✍ Panchal, Janki M.; Lairson, David R.; Chan, Wenyaw; Du, Xianglin L. 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 320 KB

PCN96 Costs of Adjuvant Chemotherapy wit

PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer: Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOX

✍ Calderillo, G.; Melchor, J.; Ruiz, E.; Meneses, A.; Albarran, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

3600 POSTER Costs of Adjuvant Chemothera

3600 POSTER Costs of Adjuvant Chemotherapy With Oxaliplatin in Stage III Colon Cancer – Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOX

✍ G. Calderillo Ruiz; J. Melchor; E. Ruiz; A. Herrera; A. Meneses; A. Albarran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Assessing the initiation and completion

Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer

✍ Chung-Yuan Hu; George L. Delclos; Wenyaw Chan; Xianglin L. Du 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 264 KB

Validation of the 12-Gene Colon Cancer R

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

✍ Yothers, G.; O'Connell, M. J.; Lee, M.; Lopatin, M.; Clark-Langone, K. M.; Millw 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 334 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB